| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $1.26 (Beat by $0.06) |
| EPS GAAP Actual | $1.26 (Beat by $0.06) |
| Revenue Actual | $6.442B |
| Revenue Surprise | Beat by $6442M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.31379 |
| EPS GAAP Estimate | $1.31379 |
| Revenue Estimate | $7.748909281B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 8.18 | 14.39 | 8.08984 | 8.3411 | 1 |
| Sep 2029 | 6.7 | 17.57 | 6.58317 | 6.84127 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.21 | -1.03426 | 6.442B | -14.78% | -1238.07M |
| FQ2 2025 (Jun 2025) | 1.07 | 1.07 | 0B | -INF% | 0M |
| FQ1 2025 (Mar 2025) | 0.73 | 0.73 | 5.676B | -18.02% | 5676M |
| FQ4 2024 (Dec 2024) | 0.55 | 0.55 | 5.426B | -12.31% | 5426M |
| FQ3 2024 (Sep 2024) | 0.95 | 0.95 | 7.394B | 6.6% | 7394M |
| FQ2 2024 (Jun 2024) | 1.45 | 1.45 | 2.488B | -186.7% | 2488M |
| FQ1 2024 (Mar 2024) | -0.41 | -0.41 | 6.699B | 100% | 6699M |
| FQ4 2023 (Dec 2023) | 0.55 | 0.55 | 6.094B | 100% | 6094M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.31379
Consensus Revenue Estimates
7.748909281B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 1.6315 | -- | 1.60048 | 1.67366 | 6 |
| FQ1 2028 (Mar 2028) | 1.4571 | -- | 1.42939 | 1.49475 | 4 |
| FQ4 2027 (Dec 2027) | 1.1099 | -- | 1.0888 | 1.13858 | 5 |
| FQ2 2027 (Jun 2027) | 1.2951 | -- | 1.26208 | 1.38738 | 4 |
| FQ1 2027 (Mar 2027) | 0.9756 | -- | 0.95073 | 1.04511 | 4 |
| FQ4 2026 (Oct 2026) | 1.42679 | -- | 1.39217 | 1.47029 | 4 |
| FQ3 2026 (Jul 2026) | 1.34569 | 84.39 | 1.31304 | 1.38672 | 4 |
| FQ2 2026 (Jun 2026) | 1.36755 | 21.76 | 1.33442 | 1.40737 | 4 |
| FQ1 2026 (Mar 2026) | 0.99558 | 26.68 | 0.97146 | 1.02457 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 6.62B | -- | 6.52B | 6.75B | 5 |
| FQ1 2028 (Mar 2028) | 6.6B | -- | 6.51B | 6.74B | 2 |
| FQ4 2027 (Dec 2027) | 6.59B | -- | 6.49B | 6.72B | 3 |
| FQ2 2027 (Jun 2027) | 3.02B | -- | 2.96B | 3.19B | 4 |
| FQ1 2027 (Mar 2027) | 3.01B | -- | 2.95B | 3.18B | 7 |
| FQ4 2026 (Oct 2026) | 8.07B | -- | 7.92B | 8.26B | 5 |
| FQ3 2026 (Jul 2026) | 8.05B | 19.95 | 7.9B | 8.24B | 5 |
| FQ2 2026 (Jun 2026) | 8.05B | -- | 7.9B | 8.23B | 5 |
| FQ1 2026 (Mar 2026) | 7.38B | 23.08 | 7.24B | 7.54B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.24426 | 0.21 | -1.03426 | -492.5% |
| FQ2 2025 (Jun 2025) | 1.07 | 1.07 | 100% | |
| FQ1 2025 (Mar 2025) | 0.73 | 0.73 | 100% | |
| FQ4 2024 (Dec 2024) | 0.55 | 0.55 | 100% | |
| FQ3 2024 (Sep 2024) | 0.95 | 0.95 | 100% | |
| FQ2 2024 (Jun 2024) | 1.45 | 1.45 | 100% | |
| FQ1 2024 (Mar 2024) | -0.41 | -0.41 | 100% | |
| FQ4 2023 (Dec 2023) | 0.55 | 0.55 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $7.68B | $6.44B | $-1238.07M | -19.22% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $5.68B | $5676M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $5.43B | $5426M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $7.39B | $7394M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.49B | $2488M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $6.7B | $6699M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $6.09B | $6094M | 100% |